DCGO Investor Presentation

Page 1

Investor Presentation © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go High quality, highly accessible healthcare For all

Page 2

Disclaimer This presentation is being delivered solely for informational purposes. No representation or warranty, express or implied, is made by DocGo, its affiliates, or any of their respective directors, officers, shareholders, members, partners or representatives as to the accuracy or completeness of any information in this presentation. Except where otherwise indicated, this presentation speaks as of the date hereof and is necessarily based upon the information as of the date hereof, all of which is subject to change. DocGo has no obligation to update, review or reaffirm this presentation. Nothing contained in this presentation is, or shall be relied upon as, a promise or representation as to the past, present or future. Forward Looking Statements This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the plans, strategies, outcomes, and prospects, both business and financial, of DocGo, including DocGo’s provision of services and the benefits of such services; the benefits of the SteadyMD acquisition; DocGo’s growth and the expansion of DocGo’s care gap closure and other programs; current and future business opportunities; and M&A activity. These statements are based on the beliefs and assumptions of DocGo’s management. Although DocGo believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, DocGo cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words “believes,” “estimates,” “expects,” “projects,” “forecasts,” “may,” “might,” “will,” “should,” “could,” “can,” “would,” “design,” “potential,” “seeks,” “plans,” “scheduled,” “anticipates,” “intends” or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond DocGo’s control, and which may cause DocGo’s actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in DocGo’s forward-looking statements, including, but not limited to the following: DocGo’s ability to successfully to deliver on its business strategies or models, plans and goals, including the expansion of its programs with hospital systems, payers, providers, municipalities and other strategic partners; DocGo’s ability to establish, maintain and grow customer relationships; DocGo’s ability to execute projects to the satisfaction of its customers; DocGo’s ability to maintain or grow its cash balances; DocGo’s ability to compete effectively in a highly competitive industry; DocGo’s ability to effectively manage its growth; DocGo’s financial performance and future prospects; DocGo’s ability to expand geographically; DocGo’s M&A activity and the success of its acquisition strategy; overall macroeconomic and geopolitical conditions; potential changes in federal, state or local government policies or priorities; legislative and regulatory actions; the impact of legal proceedings and compliance risk; the impact on DocGo’s business and reputation in the event of information technology system failures, network disruptions, cyber incidents or losses or unauthorized access to, or release of, confidential information; DocGo’s ability to comply with laws and regulations regarding data privacy and protection; and other risk factors included in DocGo’s filings with the Securities and Exchange Commission. Moreover, DocGo operates in a very competitive and rapidly changing environment. New risks and uncertainties emerge from time to time, and it is not possible for DocGo to predict all risks and uncertainties that could have an impact on the forward-looking statements contained in this presentation. In addition, statements preceded by “we believe” and similar statements reflect DocGo’s beliefs and opinions on the relevant subject. These statements are based on information available to DocGo as of the date of this presentation, and, while DocGo believes that information provides a reasonable basis for these statements, that information may be limited or incomplete. DocGo’s statements should not be read to indicate that DocGo has conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. The forward-looking statements made in this presentation are based on events or circumstances as of the date on which the statements are made. DocGo undertakes no obligation to update any forward-looking statements made in this presentation to reflect events or circumstances after the date of this presentation or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law. DocGo may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements. DocGo’s forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments. Non-GAAP Financial Information This presentation includes references to financial measures that are calculated and presented on the basis of methodologies other than in accordance with generally accepted accounting principles in the United States of America (“GAAP”), such as Adjusted Earnings Before Interest, Tax, Depreciation and Amortization (“Adjusted EBITDA”) and adjusted gross margin. DocGo has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this presentation that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this presentation. The non-GAAP financial measures in this presentation may differ from similarly titled measures used by other companies. A reconciliation of certain of these non-GAAP financial measures can be found in the Appendix to this presentation. Market and Industry Data Market data and industry data used throughout this presentation is based on information derived from third party sources, the knowledge of the DocGo management team regarding its industries and businesses and the DocGo management team’s good faith estimates. While management of DocGo believes that the third party sources from which market and industry data has been derived are reputable, DocGo has not independently verified such market and industry data, and you are cautioned not to give undue weight to such market and industry data. 2© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 3

LEADING PROVIDER OF TECH-DRIVEN MOBILE CARE RAPIDLY GROWING CARE IN THE HOME BUSINESS The DocGO Thesis FOUNDATIONAL, EXPANDING MEDICAL TRANSPORT BUSINESS PROPRIETARY TECHNOLOGY BACKBONE MASSIVE EXPANDING TAM VISIONARY LEADERSHIP TEAM STRONG BALANCE SHEET & RESOURCES TO SUPPORT GROWTH 3

Page 4

Service lines Mobile health care Innovative approach using upskilled clinicians and virtual care providers to provide treatment in the comfort of a patient’s home, office or community setting. 3,000+ Clinical Staff 900+ Mobile Health Vehicles Medical transportation MANAGEMENT Technology - powered, state - of - the - art fleet and skilled EMS professionals to provide medical transportation and management. Remote Patient Monitoring Empowers care teams with continuous insight into patient health, driving smarter care plans and stronger patient engagement. 10 million+ Patients served since 2015 +92 Patient NPS score 1 Key Customers: Health Systems & Health Plans 31 states and the UK + 50 state virtual care network 4© 2 0 2 5 A l l R i g h t s R e s e r v e d – D o c G o A MISSION to Deliver healthcare at any address DocGO is a Leading Provider of technology-enabled mobile healthcare, at unrivaled scale 1. as of 9/30/25

Page 5

Turbocharged with the Newly-acquired SteadyMD 900K+ Annual telehealth visits • B2B telehealth in all 50 states • Lab ordering and follow - up care • On - demand urgent care • Virtual primary care • Provider panel with hundreds of board - certified MDs, NPs, and therapists 9 years Operating history Synergistic Services within DocGo's Service Lines $25+ Million 2025E Revenue* EBITDA Projected positive going forward* © 2 0 2 5 A l l R i g ht s R e s e r ve d – D oc Go 5 • Developer - friendly APIs for scale and operational efficiency • White - Label Telehealth Platform • Digital clinic integrated with leading EHRs • Clinical credentialing expertise Integrated Technology Platform SteadyMD provides key infrastructure to its partners: an on - demand clinician workforce, day - to - day clinical operations, and world - class product and technology. 2M+ Annual Lab orders * Based on projected, unaudited information available to DocGo and SteadyMD as of 11/10/25. As of September 30, 2025, SteadyMD recorded revenues of $20 million for the January 1, 2025 - September 30, 2025 period. Inclusion of the prospective financial information in this Presentation should not be regarded as a representation by any person that the results contained in the prospective financial information will be achieved. DocGo is not updating or reaffirming such prospective financial information at this time. See also the Certain Financial Data & Projections -Related Disclaimer and the Forward -Looking Information Disclaimer included on slide 2 in this presentation. 50 State s SteadyMD provides virtual care for top consumer, healthcare and digital wellness brands, including multiple Fortune 10 customers. Providing DocGowith a 50-state virtual care clinical network

Page 6

HOW STEADYMD BENEFITS DOCGO 50 - state virtual provider network augment’s DocGo’s in - home care More efficient use of hundreds of telehealth - based providers, potentially garnering up to 10% GM 1 improvement Quicker launch into new geographies due to their scale and presence Ability to cross - sell B2B telehealth services to our partners HOW DOCGO BENEFITS STEADYMD Deployable mobile health resources add new dimension to SteadyMD’s virtual care Immediate expected cost synergies and accretive EBITDA in 2026 Augment services to laboratory customers with in - home phlebotomy & specimen collection Expand virtual primary care service capabilities through in - home medical visits 6© 2 0 2 5 A l l R i g h t s R e s e r v e d – D o c G o A Strategic acquisition driving incremental value *Based on management's plans and projections as of 11/10/25. Inclusion of the prospective financial information in this Presentation should not be regarded as a representation by any person that the results contained in the prospective financial information will be achieved. DocGo is not updating or reaffirming such prospective financial information at this time. See also the Certain Financial Data & Projections-Related Disclaimer and the Forward- Looking Information Disclaimer included on slide 2 in this presentation.

Page 7

$0 $200,000,000 $400,000,000 $600,000,000 $800,000,000 2021 2022 2023 2024 2025 (Guidance) Medical Transportation Payer and Provider Population Health Strong core revenue growth and balance sheet DocGo has the resources to support continued business growth Annual Revenues 2021-2024 + 2025 and 2026 Guidance Balance sheet highlights (Including Covid/Migrant) Core Business $0 $100,000,000 $200,000,000 $300,000,000 $400,000,000 $500,000,000 $600,000,000 $700,000,000 2021 2022 2023 2024 2025 (Guidance) 2026 (Guidance) 1. 2025 and 2026 guidance as of November 10, 2025. DocGo is not updating or reaffirming its 2025 or 2026 guidance at this time. 1 1 7 © 2025 All Rights Reserved – DocGo Total Assets Total Shareholders Equity Book Value / Share Shares Outstanding $309,602,652 100,133,953 12/31/21 $227,057,024 $2.27 $393,277,628 102,411,162 12/31/22 $278,927,391 $2.72 $490,451,957 104,055,168 12/31/23 $305,170,956 $2.93 $455,621,132 101,910,883 12/31/24 $315,179,130 $3.09 $353,782,879 97,813,372 9/30/25 $260,661,887 $2.66

Page 8

Improving Balance Sheet Quarterly Accounts Receivable, 2022-2025 (in $MM) Quarterly DSO (Days Sales Outstanding), 2022-2025 (Based on trailing 12 - month revenues) DocGo continues to convert accounts receivable to cash Total net cash of $95.2M on 9/30/25 compared to $78.5M in net cash on 9/30/24 8© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go 0 20 40 60 80 100 120 140 160 180 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 0 50 100 150 200 250 300 Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025

Page 9

Q3 2025 Results & business highlights Q3 RESULTS $70.8M 33.0% $7.2M $0 Total revenue Adjusted gross margin1 Adjusted ebitda1 loss Amount outstanding on line of credit $95.2 M $20.7M 36.2% $50.1M Total cash Mobile health segment revenue Mobile health segment Adjusted gross margin1 Medical transportation segment revenue 31.7%Medical transportation segment Adjusted gross margin1 1. Adjusted gross margin and adjusted EBITDA are non - GAAP measures. See Appendix for additional information on these non - GAAP measures and reconciliations to the most comparable GAAP measures. Q3 2025 BUSINESS HIGHLIGHTS • Company achieved record volumes across all major business lines, with US medical transportation increasing 2.5%, care gap closure and transitions of care increasing 320%, mobile phlebotomy increasing 11%, and remote patient monitoring increasing 6%, when comparing third quarter 2025 to third quarter 2024. • Surpassed 1.3 million patients assigned by the Company’s payer and provider partners to engage for care gap closure services, up from 1.2 million last quarter. • Ramped services under a multi - year contract with one of the largest academic medical systems in the New York metro area to provide dedicated ambulance services and coordinate all discharge transportation through DocGo’s proprietary digital transportation management platform. • Launched new mobile health vaccination program for San Diego County. • Entered agreement to provide medical transportation services to Albany Stratton VA Medical Center. • Subsequent to quarter end, entered agreement to launch care gap closure program in New Mexico with national insurance provider. • Subsequent to quarter end, entered agreement to provide longitudinal care services for a major health plan in California. Utilizing a combination of telehealth and on - site care, the Company will offer preventative care, chronic care management and transitions of care services to 10,000 plan members. • Subsequent to quarter end, acquired virtual care platform SteadyMD , expanding telehealth services across all 50 states to help drive revenue growth and achieve operational synergies. 9

Page 10

The CDC estimates that 90% of the nation’s $4.5 trillion in annual health care expenditures are for people with chronic diseases and mental health conditions. This creates substantial challenges for payers and providers, and is helping drive demand for DocGo’s services. Chronic Disease is a massive U.s. healthcare issue 10© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 11

Tailored solutions for key segments Designed to treat chronic disease and help keep people out of the hospital Key Services: Gap closure, Primary Care provider Services, Virtual care management, population health, Medical Staffing Value Proposition Increase access to care by treating bedbound and unattributed patients, Lower total cost of care Key Services: Medical Transport, Transitional care management (TCM) Value Proposition Efficient, reliable transportation and digital management platform, ed readmission program savings 11© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 12

Segment Overview: MOBILE HEALTH Payers and providers are seeking solutions that increase access to care for their patients, improve their quality metrics, and reduce their overall cost DocGo offers a broad range of mobile health solutions, including mobile phlebotomy, virtual care, urgent care, care gap closure, transitional care management, primary care, and additional services that bring care to patients Quality care at lower cost due to on - site LPN / remote APP combination Ability to close over 40 different care gaps in the home Proprietary tech platform drives efficiency for logistics, scheduling, and patient communications Major customers include Total addressable market *National Health Expenditure Projections, 2022 – 31 (peer - reviewed report by Centers for Medicare and Medicaid Services actuaries, published in Health Affairs in 6/23) **Bain & Company “The Future of Primary Care: Traditional and Nontraditional Models Continue to Evolve” (report published 12/24) $250 billion Potential size of U.s.at home car e market, according to CMS Actuaries* 30% ofPCP Market expected to shift to nonTraditio na lproviders, according to Ba in & co** 12© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 13

On-Site Clinical Staff ▪ Certified Medical Assistant ▪ Emergency Medical Technician ▪ Licensed Practical Nurse ▪ Paramedic Flexible, turnkey solutions for ongoing health management and care gap closure Intelligent use of appropriately - skilled h ealthcare professionals creates efficiency with quality care Common procedures executed at fraction of average industry cost Cost-effective clinical service delivery Remote Clinical Staff ▪ Licensed Medical Physician ▪ Physician Assistant ▪ Nurse Practitioner ▪ Registered Nurse BENEFITSSERVICE DELIVERY Our care delivery model pairs Lower-cost field clinicians directed by higher-cost virtual APPs 13© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 14

COMPREHENSIVE MOBILE HEALTH PLATFORM Quality & Gap Closure Transitional Care Management Mobile & Staffed Clinics Urgent Care PCP Program Place of Service In Home and/or Telehealth In Home and/or Telehealth Anywhere with parking or a partner clinic In Home and/or Telehealth In Home and/or Telehealth Value provided To Health Plans • Ability to close over 30 different gaps in care • Higher quality ratings • Preventive care for unengaged members • Better health outcomes • Lower medical costs • Lower hospital readmissions • Higher quality ratings • Better health outcomes • Lower medical costs • Access for underserved communities • Member Enrollment • Better health outcomes • Lower medical costs • Brand marketing • ED Diversion • Access for homebound or mobility challenged • Lower medical costs • Highly proactive PCP care for historically unengaged • Better health outcomes • Lower medical costs Value provided to patients Convenient access to high quality health care that meets the patient where they are, often at no or low patient cost Mobile Phlebotomy In Home • Increased access for bedbound members • Better health outcomes • Lower medical costs To meet a wide range of clinical needs and improve access to care 14© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 15

Segment Overview: Medical Transportation Provide non - emergency medical transport between clinical settings and/or patient’s residences Insurance/Medicare/Medicaid and facility pay Transitioning legacy “fee for service” contracts to more lucrative leased hour contracts that provide greater financial predictability Proprietary technology provides increased transparency, enhanced efficiency, and integration with leading EMRs, including Epic Total addressable market $7-$13 billion Major customers include *Source: US, Ambulance Only. Management estimates. * 15© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go Projected to transport over 700,000 patients in 2025

Page 16

proprietary mobile health management platform Modern Architecture and Design EHR INTEGRATION ▪ Integrated with leading EHRs to enhance value, ease adoption of DocGo services PROPRIETARY TECHNOLOGY AND UX ▪ DocGo’s technology platform and self - service UIs facilitate service delivery and results data ▪ Purpose - built fleet management (CAD) system with dynamic routing and Google traffic integration PATIENT - FACING MOBILE APP ▪ DocGo On - Demand for iOS and Android provides instant booking of health care visits, care team messaging, and access to results SHARELINK TM ▪ ShareLink TM technology provides hospitals, patients and caregivers real - time vehicle location, accurate ETAs and peace of mind HIPAA COMPLIANT, SOC 2 and ISO 27001 CERTIFIED TECH ▪ Designed to manage sensitive healthcare data and follow industry best practices and compliance frameworks BUILT AN AI SOLUTION TO HELP AUTOMATE PATIENT OUTREACH ▪ Text - based appointment reminder and rescheduling agent launched 5/1/25 ▪ Training agent to engage and sign patients up for gap closure program visits Our digital platform is integrated with industry standard EHRs, providing seamless care logistics throughout the patient journey Optimize daily deployment of over 500 medical care units + Ai-enabled patient engagement © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go 16

Page 17

growth in key metrics with increases anticipated due to strong demand for our services 17 Patients Assigned for Gap Closure & TCM Gap Closure & TCM Visits Completed PCP Visits Completed Mobile Phlebotomy Visits 2023 (actual) 75,000 7,915 2024 (actual) 2025 (projected) 1 2026 (projected) 1 ‘23 – ’26 CAGR 500,000 800,000 1,069,500 142% 90% 10,607 31,679 54,693 - 115,769 144 1,000 42,000 1,608%* 22% 108,772 127,075 213,117 *’24-’26 CAGR © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go Virtual Care Visits & Lab Orders - - 3,500,000 4,400,000 25%* *’25-’26 CAGR 1. Projections as of November 10, 2025. DocGo is not updating or reaffirming its projections at this time.

Page 18

© 2025 All Rights Reserved – DocGo 18 Experienced LEADERSHIP Team 18 Norm Rosenberg Chief Financial Officer and Treasurer ▪ Joined DocGo in March 2022 as Chief Operating Officer ▪ Promoted to President in January 2023, and CEO in September 2023 ▪ Spent 10 years at Google, where he most recently served as Global Head of Enterprise Partnerships for Devices and Services ▪ MBA from the Wharton School Chief Executive Officer Lee Bienstock ▪ Joined DocGo in October 2024 as independent Chair of the Board ▪ Extensive background within healthcare and medical industry innovation, including eight - year tenure as CEO of Jefferson Health, CEO of USF Health, and Dean of Drexel University College of Medicine ▪ Currently serves as Special Advisor of VC firm General Catalyst, and as Chief Medical Officer of Abundant Venture Partners Chair of the Board Dr. Stephen klasko ▪ Joined DocGo in January 2020 as CFO of Ambulnz Holdings, LLC. Promoted to CFO of DocGo Inc. in January 2023, and Treasurer in September 2023 ▪ Has overseen more than $1 billion in acquisitions and divestitures, as well as several restructurings ▪ Has directly managed business in both the B2B and B2C space in the insurance and telecom industries Stephen Sugrue, ESQ. Chief Compliance Officer ▪ Joined DocGo in 2021, to oversee company’s Compliance and Ethics functions ▪ Healthcare experience includes serving as Compliance Officer and Compliance Counsel for large health systems, as attorney for healthcare - focused law firms, and for the NY State AG ▪ Clinical background includes over 20 years as a critical care RN in a hospital setting, as Director of Operations for an ambulance company, and as both a paramedic and EMT

Page 19

Proprietary Technology AND EMR Integrations Laboratory License Clinical Practice Group Medicare AND Managed Care Credentials DocGo has continued to expand its moat, preserving its value proposition by relying on technology to efficiently deploy our resources. The formulaic balance of technology and human specialty has improved DocGo’s unit economics, positioning the company to disrupt both its competitors and the healthcare market overall. Vertical integration creates our Competitive Moat Proven ability with health record management and billing Medicare, Medicaid and commercial payers Physicians practice positions our service offering as a nimble alternative to traditional primary and urgent care Licensure enables the company to facilitate the sample collection, processing, diagnostics and follow up Proven ability to rapidly deploy ‘just - in - time’ mobile healthcare and clinical solutions contributes to our competitive advantage Technology is the nucleus of the value proposition via a proprietary platform that utilizes dynamic optimization, patient EHR, hospital integration, and technology - based staffing to create actionable insights for our partners 19© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go Rapidly deployable staff AND purpose-built fleet

Page 20

Why DocGo? We are unique in comprehensive care delivery. 20

Page 21

Growth drivers DocGo’s growth strategy will be fueled by the following key components Legacy Customers Reducing Hospitalization Payer PROGRAMS VIRTUAL CARE MANAGEMENT RObust pipeline M&A Channel Strong, long - term relationships with leading health system, payer and provider customers ED d epartment admission reduction and hospital readmission reduction programs Growing care gap closure programs provide patient volume with minimal customer acquisition costs Large opportunities across business verticals represent multi - million - dollar deals Proactive remote monitoring and health coaching for patients with chronic diseases Disciplined M&A approach is expected to help gain access to new services and regions 21© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 22

Key Takeaways Unique value proposition to Healthcare Systems and Payers & Providers Building recurring revenue base with highly attractive customers Mission - driven company with world - class management team Defensible competitive technology advantage and vertical integration Strong balance sheet to support continued growth 22© 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 24

Where homebound PATIENTS benefit from onsite treatment, we go. Where long waits in busy emergency rooms do more harm than good, we go. Where underserved populations need better care, we go. Where basic telehealth providers stop, we go. And when all reason says it can’t be done, leave well enough alone and quit while you’re ahead, we do what our company has always done. We go. © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go

Page 25

APPENDIX: Reconciliation of Non-GAAP Measures © 2 0 2 5 A l l R i g h t s R e s e r ve d – D o c Go The table below reflects the reconciliation of net income (loss) to adjusted EBITDA for the three months ended September 30, 2025 (in millions): The table below reflects the reconciliation of GAAP gross margin and adjusted gross margin for the three months ended September 30, 2025: 25

Slides